CS
ASXC

Credit Suisse’s Asensus Surgical, Inc. ASXC Stock Holding History

Credit Suisse’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed – – 3808
2022
Q4 		$0 Hold
1
– – ﹤0.01% 4164
2022
Q3 		$0 Hold
1
– – ﹤0.01% 4379
2022
Q2 		$0 Sell
1
-14,581
-100% -$6.51K ﹤0.01% 4421
2022
Q1 		$9K Sell
14,582
-9,646
-40% -$7.43K ﹤0.01% 3547
2021
Q4 		$27K Buy
+24,228
New +$37.4K ﹤0.01% 4439
2020
Q2 		– Sell
-62,097
Closed -$22K – 4176
2020
Q1 		$22K Buy
+62,097
New +$64.8K ﹤0.01% 3939
2019
Q4 		– Sell
-8,746
Closed -$70K – 4370
2019
Q3 		$70K Buy
8,746
+1,054
+14% +$14.3K ﹤0.01% 4000
2019
Q2 		$135K Sell
7,692
-567
-7% -$12.4K ﹤0.01% 3919
2019
Q1 		$255K Buy
8,259
+1,483
+22% +$49.7K ﹤0.01% 3673
2018
Q4 		$199K Sell
6,776
-17,905
-73% -$814K ﹤0.01% 3675
2018
Q3 		$1.86M Buy
24,681
+21,592
+699% +$1.46M ﹤0.01% 2403
2018
Q2 		$175K Buy
3,089
+1,151
+59% +$41.9K ﹤0.01% 3783
2018
Q1 		$43K Buy
+1,938
New +$44.3K ﹤0.01% 3892
2017
Q4 		– Sell
-92,359
Closed -$1.72M – 4244
2017
Q3 		$1.72M Sell
92,359
-523
-0.6% -$6.08K ﹤0.01% 2673
2017
Q2 		$857K Buy
92,882
+91,239
+5,553% +$868K ﹤0.01% 2790
2017
Q1 		$26K Sell
1,643
-1,237
-43% -$21.4K ﹤0.01% 3768
2016
Q4 		$48K Buy
2,880
+83
+3% +$1.7K ﹤0.01% 4025
2016
Q3 		$61K Sell
2,797
-1,858
-40% -$34K ﹤0.01% 3996
2016
Q2 		$73K Buy
4,655
+2,821
+154% +$88.6K ﹤0.01% 4105
2016
Q1 		$101K Buy
+1,834
New +$78.6K ﹤0.01% 3825
2015
Q4 		– Sell
-966
Closed -$28K – 4391
2015
Q3 		$28K Buy
+966
New +$35.8K ﹤0.01% 4212

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's ASXC Position: Q1 2023 in Review

Credit Suisse sold out of Asensus Surgical, Inc. (ASXC) in Q1 2023, closing a stake of 1 share.

Credit Suisse first reported a position in ASXC in Q3 2015 and held it in 21 quarters. The position peaked at $1.86M in Q3 2018. 79 funds tracked by Wall St. Rank hold ASXC as of Q1 2023.

  • Credit Suisse reported no remaining Asensus Surgical, Inc. position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1 Asensus Surgical, Inc. share in Q1 2023.
  • Credit Suisse first reported a position in Asensus Surgical, Inc. in Q3 2015 and held it in 21 quarters.
  • Credit Suisse's Asensus Surgical, Inc. position peaked at $1.86M in Q3 2018.
  • 79 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.